Also trades as: HOCPY (OTC) · $vol 6M · HOCPF (OTC) · $vol 0M

¥24,500.00 ($155.37)

+320.00 (+1.32%)

Weekly Expected Move ±3.6%

¥22443 ¥23311 ¥24180 ¥25049 ¥25917

JPX · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 48 · ¥8.09T mcap · 335M float · 0.325% daily turnover

Revenue

$947.7B +9.4% ▲

5Y CAGR: +11.6%

Gross Profit

$748.6B +7.9% ▲

5Y CAGR: +12.0%

Operating Income

$280.4B -18.4% ▼

5Y CAGR: +4.5%

Net Income

$253.1B +25.2% ▲

5Y CAGR: +15.1%

EPS (Diluted)

$743.82 +28.0% ▲

5Y CAGR: +17.3%

EBITDA

$387.9B +25.3% ▲

5Y CAGR: +14.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$661.5B	$723.6B	$762.6B	$866.0B	$947.7B
YoY Growth	+20.7%	+9.4%	+5.4%	+13.6%	+9.4%
Cost of Revenue	$150.4B	$156.5B	$156.3B	$172.5B	$199.1B
Gross Profit	$511.0B	$567.1B	$606.3B	$693.6B	$748.6B
Gross Margin	77.3%	78.4%	79.5%	80.1%	79.0%
R&D Expenses	$25.4B	$29.4B	$33.0B	$35.3B	$0
SG&A Expenses	$213.0B	$245.0B	$276.6B	$314.6B	$468.2B
Operating Expenses	$238.4B	$274.5B	$309.7B	$349.9B	$468.2B
Operating Income	$272.6B	$292.6B	$296.6B	$343.6B	$280.4B
Operating Margin	41.2%	40.4%	38.9%	39.7%	29.6%
Interest Expense	$712M	$834M	$1.1B	$1.3B	$2.0B
Income Before Tax	$210.7B	$215.8B	$236.6B	$260.0B	$327.7B
Tax Expense	$45.4B	$47.0B	$54.0B	$58.2B	$76.2B
Net Income	$164.5B	$168.6B	$181.4B	$202.1B	$253.1B
Net Margin	24.9%	23.3%	23.8%	23.3%	26.7%
EPS (Diluted)	$445.93	$469.47	$515.27	$581.26	$743.82
EBITDA	$254.5B	$266.2B	$284.4B	$309.5B	$387.9B
Shares Outstanding	369M	359M	352M	348M	340M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$213.8B	$214.7B	$220.8B	$216.8B	$220.4B	$234.5B	$244.7B	$248.1B
Cost of Revenue	$44.8B	$42.6B	$42.3B	$42.8B	$44.5B	$48.0B	$50.1B	$56.6B
Gross Profit	$169.0B	$172.0B	$178.6B	$174.0B	$175.9B	$186.5B	$194.6B	$191.6B
Gross Margin	79.0%	80.1%	80.9%	80.3%	79.8%	79.5%	79.5%	77.2%
R&D Expenses	$0	$0	$0	$0	$8.5B	$9.2B	$9.2B	$0
SG&A Expenses	$111.6B	$109.5B	$113.7B	$109.5B	$101.6B	$109.3B	$112.5B	$117.9B
Operating Expenses	$111.6B	$109.5B	$113.7B	$109.5B	$110.0B	$118.5B	$121.7B	$117.9B
Operating Income	$57.4B	$62.5B	$64.9B	$64.5B	$65.9B	$68.0B	$72.9B	$73.6B
Operating Margin	26.8%	29.1%	29.4%	29.8%	29.9%	29.0%	29.8%	29.7%
Interest Expense	$331M	$335M	$366M	$427M	$488M	$500M	$497M	$506M
Income Before Tax	$64.2B	$62.8B	$65.2B	$67.7B	$67.4B	$71.9B	$110.8B	$77.6B
Tax Expense	$17.1B	$9.9B	$14.5B	$16.7B	$16.0B	$17.0B	$19.6B	$23.7B
Net Income	$47.2B	$52.9B	$50.5B	$51.5B	$51.8B	$55.4B	$91.6B	$54.2B
Net Margin	22.1%	24.7%	22.9%	23.8%	23.5%	23.6%	37.4%	21.9%
EPS (Diluted)	$134.62	$151.97	$145.30	$149.50	$151.22	$161.92	$270.50	$161.04
EBITDA	$76.1B	$74.9B	$77.9B	$80.7B	$80.4B	$86.3B	$126.3B	$94.5B
Shares Outstanding	350M	355M	347M	345M	343M	342M	339M	337M

7741.T JPX